Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma https://t.co/mJRXqAXryB
Also provided this helpful link to review from earlier this year. https://t.co/FAlkdg960O https://t.co/ngzVAReTLK
RT @BloodJournal: Evidence-based review: Surveillance imaging for malignant #lymphoma https://t.co/Fbb8fCFKQG
RT @BloodJournal: Evidence-based review: Surveillance imaging for malignant #lymphoma https://t.co/Fbb8fCFKQG
Imaging for DLBCL and HL https://t.co/09v55L7CRc
Further evidence of limited value of rigorous imaging surveillance in #DLBCL @MayoClinic https://t.co/S4k3R1eHil https://t.co/qajk1SFFde
RT @BloodJournal: Evidence-based review: Surveillance imaging for malignant #lymphoma https://t.co/Fbb8fCFKQG
Evidence-based review: Surveillance imaging for malignant #lymphoma https://t.co/Fbb8fCFKQG
Christopher Flowers, MD et al. Evaluating surveillance imaging for diffuse large B-cell lymphoma & Hodgkin lymphoma: https://t.co/rnHq4cOmcT https://t.co/PMuOaOENVe
RT @gedefo_sefh: "Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma" https://t.co/djeHn6jGw9
Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma | Blood Journal https://t.co/3ErhYZKITa
RT @DrRaulCordoba: @BloodJournal Evaluating surveillance imaging for diffuse large B-cell #lymphoma and #Hodgkin lymphoma https://t.co/xiQo…
RT @bloodworkapp: #lymphoma surveillance imaging still doesn't impact survival or QOL. Clinical signs; timely access to care paramount http…
@BloodJournal Evaluating surveillance imaging for diffuse large B-cell #lymphoma and #Hodgkin lymphoma https://t.co/xiQowoEPMs #lymsm
#lymphoma surveillance imaging still doesn't impact survival or QOL. Clinical signs; timely access to care paramount https://t.co/QKmDitpmNG
"Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma" https://t.co/djeHn6jGw9
Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin #lymphoma https://t.co/cB664u1KlW
Important review by @ChrisRFlowersMD et al on the (lack of) utility of screening survivors of HL or DLBCL: https://t.co/VJGCd8EVjg
RT @MaurerStats: Nice review on surveillance imaging for DLBCL and HL in @BloodJournal by @jonathonbcohen, @drcthompson et al https://t.co/…
RT @MaurerStats: Nice review on surveillance imaging for DLBCL and HL in @BloodJournal by @jonathonbcohen, @drcthompson et al https://t.co/…
Nice review on surveillance imaging for DLBCL and HL in @BloodJournal by @jonathonbcohen, @drcthompson et al https://t.co/8n8cgeY9ne #lymsm
Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin #lymphoma https://t.co/eMKTbS976I
Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma. - PubMed - NCBI https://t.co/aALv06HPVG
Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma https://t.co/3wp8MxD8lP
RT @DrRaulCordoba: Evaluating surveillance imaging for diffuse large B-cell lymphoma and #Hodgkin #lymphoma https://t.co/nLZzFYmLK0 #lymsm
"Current imaging approaches do not detect most relapses prior to clinical signs and symptoms or improve survival." #lymsm https://t.co/0J0yEDqETG
Evaluating surveillance imaging for diffuse large B-cell lymphoma and #Hodgkin #lymphoma https://t.co/nLZzFYmLK0 #lymsm
"Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma" https://t.co/sNuAh86JOa